TolerogenixX

Product / Service Summary

ATMP, Zelltherapie, Therapie-Kit


Life Science & Healthcare

Startup Stage

Technology Development/ Production

B2B

Description

TolerogenixX has an innovative cell technology that can be used to suppress unwanted immune responses in the body. This novel cell therapy will revolutionize the treatment of transplant recipients and numerous autoimmune diseases.

The unique feature of the TolerogenixX method is the simple modification of white blood cells by use of the TolerogenixX therapy kit. Once infused, these modified cells suppress unwanted immune responses in the patient´s body. The first patients have already been successfully treated in a phase-I clinical study in kidney transplantation.

Due to the promising results from the phase I study, there are already preparations for the TOL-2 phase II study.


TolerogenixX Funding


TolerogenixX Team Members


Startbase Data

Added: 02.02.2018
Updated: 23.10.2019
Claimed: 05.08.2019
Verified: 19.09.2019
  • Validated team members on Startbase
  • Registered at a German Handelsregister
  • Headquarter located in Germany
  • Scalable Business Model
  • Innovative Business Model
  • Founders are still involved
  • Founders still hold shares
TolerogenixX
TolerogenixX has a patented technology that can be used to suppress unwanted immune responses in the body